Given the potential role of RIPK1 in glioma immunity due to its role in necroptosis and pyroptosis, we performed a meta-analysis using previously validated immune genetic signatures of tumor-infiltrating immune cells [34,35]. The gene discussed is RIPK1; the disease is central nervous system cancer.